Literature DB >> 2413458

Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.

U Scheefers-Borchel, G Müller-Berghaus, P Fuhge, R Eberle, N Heimburger.   

Abstract

Circulating soluble fibrin, observed in the blood of patients with ongoing intravascular coagulation, is generated from the plasma protein fibrinogen by the limited proteolytic action of thrombin. We report the production of a monoclonal antibody that discriminates between fibrin and fibrinogen in blood. The synthetic hexapeptide Gly-Pro-Arg-Val-Val-Glu, representing the amino terminus of the alpha chain of human fibrin, was used as immunogen. This hexapeptide is located within the A alpha chain of fibrinogen but becomes the amino terminus of the fibrin alpha chain, after fibrinopeptide A is removed by the action of thrombin, and thus becomes accessible for antibody binding. The monoclonal antibody we have prepared can discriminate between fibrin and fibrinogen and thus can be used in assay systems to quantitate soluble fibrin or, potentially, to image fibrin-rich thrombi.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413458      PMCID: PMC391316          DOI: 10.1073/pnas.82.20.7091

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Polymerization of fibrinogen.

Authors:  J D FERRY
Journal:  Physiol Rev       Date:  1954-10       Impact factor: 37.312

2.  Cold-precipitation by heparin of a protein in rabbit and human plasma.

Authors:  L THOMAS; R T SMITH; R VON KORFF
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

3.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  [A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives].

Authors:  W König; R Geiger
Journal:  Chem Ber       Date:  1970

6.  Blood hypercoagulability and thrombosis.

Authors:  A P Fletcher; N Alkjaersig; J O'Brien; V G Tulevski
Journal:  Trans Assoc Am Physicians       Date:  1970

7.  Evidence for four different polymerization sites involved in human fibrin formation.

Authors:  S A Olexa; A Z Budzynski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

Review 8.  Antibody production by hybridomas.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Measurement of fibrinopeptide A in human blood.

Authors:  H L Nossel; I Yudelman; R E Canfield; V P Butler; K Spanondis; G D Wilner; G D Qureshi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

10.  Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis.

Authors:  H L Nossel
Journal:  Nature       Date:  1981-05-14       Impact factor: 49.962

View more
  8 in total

Review 1.  Antibody imaging in the evaluation of cardiovascular diseases.

Authors:  B A Khaw; J Narula
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 2.  New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.

Authors:  W Nieuwenhuizen
Journal:  Blut       Date:  1988-11

3.  [Diagnosis of disseminated intravascular coagulation: the value of soluble fibrin, D-dimers and fibrin(ogen) split products].

Authors:  J U Wieding; G Eisinger; H Köstering
Journal:  Klin Wochenschr       Date:  1989-08-01

4.  The sequence A alpha-(148-160) in fibrin, but not in fibrinogen, is accessible to monoclonal antibodies.

Authors:  W J Schielen; M Voskuilen; G I Tesser; W Nieuwenhuizen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Generation of an antibody with a designed specificity difference for protein C and activated protein C.

Authors:  L Zhang; F J Castellino
Journal:  J Protein Chem       Date:  1989-08

6.  The evolution of fibrin-specific targeting strategies.

Authors:  Victoria L Stefanelli; Thomas H Barker
Journal:  J Mater Chem B       Date:  2015-01-13       Impact factor: 6.331

7.  Discovery of an uncovered region in fibrin clots and its clinical significance.

Authors:  Yohei Hisada; Masahiro Yasunaga; Shingo Hanaoka; Shinji Saijou; Takashi Sugino; Atsushi Tsuji; Tsuneo Saga; Kouhei Tsumoto; Shino Manabe; Jun-ichiro Kuroda; Jun-ichi Kuratsu; Yasuhiro Matsumura
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Ultrasoft microgels displaying emergent platelet-like behaviours.

Authors:  Ashley C Brown; Sarah E Stabenfeldt; Byungwook Ahn; Riley T Hannan; Kabir S Dhada; Emily S Herman; Victoria Stefanelli; Nina Guzzetta; Alexander Alexeev; Wilbur A Lam; L Andrew Lyon; Thomas H Barker
Journal:  Nat Mater       Date:  2014-09-07       Impact factor: 43.841

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.